MX346708B - Micobacteria recombinante como vacuna para uso en humanos. - Google Patents

Micobacteria recombinante como vacuna para uso en humanos.

Info

Publication number
MX346708B
MX346708B MX2013002989A MX2013002989A MX346708B MX 346708 B MX346708 B MX 346708B MX 2013002989 A MX2013002989 A MX 2013002989A MX 2013002989 A MX2013002989 A MX 2013002989A MX 346708 B MX346708 B MX 346708B
Authority
MX
Mexico
Prior art keywords
vaccine
humans
recombinant mycobacterium
recombinant
mycobacterium
Prior art date
Application number
MX2013002989A
Other languages
English (en)
Other versions
MX2013002989A (es
Inventor
Grode Leander
Original Assignee
Vakzine Projekt Man Gmbh *
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vakzine Projekt Man Gmbh * filed Critical Vakzine Projekt Man Gmbh *
Publication of MX2013002989A publication Critical patent/MX2013002989A/es
Publication of MX346708B publication Critical patent/MX346708B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins

Abstract

La presente invención se refiere a una vacuna recombinante que proporciona inmunidad protectora especialmente contra la tuberculosis en sujetos humanos.
MX2013002989A 2010-09-20 2011-09-16 Micobacteria recombinante como vacuna para uso en humanos. MX346708B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38437510P 2010-09-20 2010-09-20
PCT/EP2011/066131 WO2012038348A1 (en) 2010-09-20 2011-09-16 Recombinant mycobacterium as vaccine for use in humans

Publications (2)

Publication Number Publication Date
MX2013002989A MX2013002989A (es) 2013-10-17
MX346708B true MX346708B (es) 2017-03-29

Family

ID=44645725

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013002989A MX346708B (es) 2010-09-20 2011-09-16 Micobacteria recombinante como vacuna para uso en humanos.

Country Status (26)

Country Link
US (1) US9084749B2 (es)
EP (2) EP2618837B1 (es)
JP (1) JP5919276B2 (es)
KR (1) KR101907222B1 (es)
CN (1) CN103118703A (es)
AU (1) AU2011304385B2 (es)
BR (1) BR112013006245A2 (es)
CA (1) CA2811158C (es)
CU (1) CU24182B1 (es)
CY (2) CY1120748T1 (es)
DK (2) DK3360569T3 (es)
EA (1) EA026661B1 (es)
ES (2) ES2784451T3 (es)
HK (1) HK1258603A1 (es)
HR (2) HRP20181387T1 (es)
HU (2) HUE048774T2 (es)
LT (2) LT3360569T (es)
MX (1) MX346708B (es)
PL (2) PL3360569T3 (es)
PT (2) PT3360569T (es)
RS (2) RS57574B1 (es)
SG (1) SG188595A1 (es)
SI (2) SI3360569T1 (es)
UA (1) UA112297C2 (es)
WO (1) WO2012038348A1 (es)
ZA (1) ZA201301187B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013015882B8 (pt) * 2010-12-21 2021-01-05 Max Planck Gesellschaft célula recombinante de mycobacterium bovis (m. bovis) do bacillus calmette-guérin (bcg) da cepa danish subtipo prague e uso da mesma
EP3090757A1 (en) 2015-05-04 2016-11-09 Vakzine Projekt Management GmbH Recombinant mycobacterium as an immunotherapeutic agent for the treatment of cancer
KR102338845B1 (ko) 2020-05-22 2021-12-13 서울대학교산학협력단 플랩 구동 장치 및 회전익기의 블레이드

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733151A (en) 1996-08-23 1998-03-31 Edsall; David Electrical clamping connection device
AUPO761697A0 (en) 1997-06-30 1997-07-24 Cardiac Crc Nominees Pty Limited Process for the purification of polyethers
EP0902086A1 (en) * 1997-08-22 1999-03-17 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Tuberculosis vaccine
CN1513551A (zh) * 2002-09-09 2004-07-21 丛繁滋 复合生物制品组合物及其制备方法
BRPI0409789B8 (pt) * 2003-04-23 2021-05-25 Max Planck Gesellschaft célula bacteriana, seus processos de preparação e seu uso, composição, e processo para a preparação de uma vacina viva
EP1649869A1 (en) * 2004-10-21 2006-04-26 Vakzine Projekt Management GmbH Combination of a recombinant mycobacterium and a biologically active agent as a vaccine

Also Published As

Publication number Publication date
CY1123049T1 (el) 2021-10-29
CN103118703A (zh) 2013-05-22
US9084749B2 (en) 2015-07-21
LT2618837T (lt) 2018-09-25
RS57574B1 (sr) 2018-11-30
PT3360569T (pt) 2020-04-17
DK3360569T3 (da) 2020-04-06
CA2811158C (en) 2019-06-25
HUE039038T2 (hu) 2018-12-28
MX2013002989A (es) 2013-10-17
AU2011304385B2 (en) 2015-02-26
JP2013538225A (ja) 2013-10-10
EP3360569A1 (en) 2018-08-15
PL3360569T3 (pl) 2020-07-27
HK1258603A1 (zh) 2019-11-15
PT2618837T (pt) 2018-10-18
KR20140017484A (ko) 2014-02-11
EP3360569B1 (en) 2020-03-18
JP5919276B2 (ja) 2016-05-18
AU2011304385A1 (en) 2013-03-21
SI2618837T1 (sl) 2018-11-30
US20130280287A1 (en) 2013-10-24
PL2618837T3 (pl) 2018-11-30
EA201300380A1 (ru) 2013-07-30
SI3360569T1 (sl) 2020-07-31
EA026661B1 (ru) 2017-05-31
UA112297C2 (uk) 2016-08-25
BR112013006245A2 (pt) 2016-06-07
EP2618837A1 (en) 2013-07-31
ZA201301187B (en) 2013-09-25
EP2618837B1 (en) 2018-08-08
KR101907222B1 (ko) 2018-10-11
WO2012038348A1 (en) 2012-03-29
HUE048774T2 (hu) 2020-08-28
RS60146B1 (sr) 2020-05-29
SG188595A1 (en) 2013-04-30
DK2618837T3 (en) 2018-10-01
CA2811158A1 (en) 2012-03-29
CU20130041A7 (es) 2013-06-28
ES2685928T3 (es) 2018-10-15
ES2784451T3 (es) 2020-09-25
HRP20200610T1 (hr) 2020-10-02
HRP20181387T1 (hr) 2018-11-02
CU24182B1 (es) 2016-07-29
LT3360569T (lt) 2020-05-11
CY1120748T1 (el) 2019-12-11

Similar Documents

Publication Publication Date Title
MX366090B (es) Combinación farmacéutica para usarse en mejorar la tolerancia a la glucosa en pacientes que padecen diabetes de tipo 2.
MX2021004211A (es) Composiciones vacuna.
WO2013183058A3 (en) Expanded device
IL237397B (en) A strain of bacteria and a preparation containing the strain of bacteria
SG191332A1 (en) Recombinant mycobacterium as a vaccine
PH12018500368A1 (en) Preparations containing amorphous emodepside
CY1123049T1 (el) Ανασυνδυασμενο μυκοβακτηριο ως εμβολιο για χρηση σε ανθρωπους
HK1209027A1 (en) Vesicular formulations, uses and methods
ZA201500270B (en) Inactivated mycobacteria for oral use in in the prevention of tuberculosis
EP2839840A4 (en) RECOMBINANT TRUMPLANT VACCINE AGAINST HUMAN FLUID
GB201106162D0 (en) Combination vaccine
MX2013005222A (es) Nuevo adyuvante.
TWM400837U (en) Denture/Protection pad device
AU345549S (en) A cape

Legal Events

Date Code Title Description
FG Grant or registration